Literature DB >> 25640811

Influenza: the rational use of oseltamivir.

Heath Kelly1, Benjamin J Cowling2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25640811     DOI: 10.1016/S0140-6736(15)60074-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Discovery of Influenza A virus neuraminidase inhibitors using support vector machine and Naïve Bayesian models.

Authors:  Wenwen Lian; Jiansong Fang; Chao Li; Xiaocong Pang; Ai-Lin Liu; Guan-Hua Du
Journal:  Mol Divers       Date:  2015-12-21       Impact factor: 2.943

2.  Forsythiaside A improves Influenza A virus infection through TLR7 signaling pathway in the lungs of mice.

Authors:  Xiao Zheng; Ziqi Chen; Shanshan Shi; Huijun Yan; Junmei Zhou; Lifang Jiang; Hongli Wang; Guanghui Hou; Zhenyou Jiang
Journal:  BMC Complement Med Ther       Date:  2022-06-22

Review 3.  Influenza in long-term care facilities.

Authors:  Louise E Lansbury; Caroline S Brown; Jonathan S Nguyen-Van-Tam
Journal:  Influenza Other Respir Viruses       Date:  2017-07-26       Impact factor: 4.380

4.  Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza.

Authors:  Aeron C Hurt; Heath Kelly
Journal:  Emerg Infect Dis       Date:  2016-06       Impact factor: 6.883

5.  ECDC expert opinion on efficacy and effectiveness of neuraminidase inhibitors published for public consultation.

Authors:  Pasi Penttinen; Mike Catchpole
Journal:  Influenza Other Respir Viruses       Date:  2016-05       Impact factor: 4.380

6.  Neuraminidase Inhibitors in Influenza Treatment and Prevention⁻Is It Time to Call It a Day?

Authors:  César Parra-Rojas; Van Kinh Nguyen; Gustavo Hernandez-Mejia; Esteban A Hernandez-Vargas
Journal:  Viruses       Date:  2018-08-25       Impact factor: 5.048

Review 7.  Point-of-care testing for respiratory viruses in adults: The current landscape and future potential.

Authors:  Nathan J Brendish; Hannah F Schiff; Tristan W Clark
Journal:  J Infect       Date:  2015-07-26       Impact factor: 6.072

8.  An Oleanolic Acid Derivative Inhibits Hemagglutinin-Mediated Entry of Influenza A Virus.

Authors:  Mengdie Ye; Yixian Liao; Li Wu; Wenbao Qi; Namrta Choudhry; Yahong Liu; Weisan Chen; Gaopeng Song; Jianxin Chen
Journal:  Viruses       Date:  2020-02-18       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.